Red ginseng-derived saponin fraction suppresses the obesity-induced inflammatory responses via Nrf2-HO-1 pathway in adipocyte-macrophage co-culture system

被引:26
|
作者
Kim, Chae Young [1 ]
Kang, Bobin [1 ]
Suh, Hyung Joo [1 ]
Choi, Hyeon-Son [2 ]
机构
[1] Korea Univ, Dept Publ Hlth Sci, Seoul 07249, South Korea
[2] Seoul Womens Univ, Coll Nat Sci, Dept Food Sci & Technol, Seoul 139774, South Korea
关键词
Obesity-induced inflammation; Co-culture; Saponin fraction; Nuclear factor (erythroid-derived 2)-like 2; (Nrf2)-hemoxygenase-1 (HO-1) signaling pathway; NRF2 SIGNALING PATHWAY; HEME OXYGENASE-1; OXIDATIVE STRESS; HIGH-FAT; ACTIVATION; PHARMACOLOGY; ADIPONECTIN; INHIBITION; ROLES; MODEL;
D O I
10.1016/j.biopha.2018.09.169
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to investigate the effect of saponin fraction (SF) from red ginseng on obesity-induced inflammatory response in a co-culture system of 3T3-L1 and RAW264.7 cells. HPLC analysis showed that SF contains more than 50% ginsenosides, and Rb1 was the most abundant ginsenoside [135.31 mu g/mg (extract)]. The production of nitric oxide and cytokines, induced by adipocyte-conditioned medium (3T3-CM), was significantly decreased by SF. SF (100 mu g/mL) suppressed the abundance of tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) by 78%, 40%, and 22%, respectively. This SF-mediated reduction in inflammatory cytokines was due to the suppression of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B alpha) phosphorylation, and translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) into the nucleus. SF also regulated adipokine expression in adipocytes, which were stimulated by macrophage-conditioned medium (RAW-CM); adiponectin expression was upregulated (> 2-fold), while resistin was downregulated (40%). In the contact system of adipocytes and macrophages, SF significantly decreases MCP-1 (37%) and IL-6 (25%) production. In the transwell system, SF (100 mu g/mL) significantly increased the abundance of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and its target protein, hemoxygenase-1 (HO-1) by 1.5 similar to 3.5-fold and 2.8 similar to 3.6-fold, respectively, thus increasing Nrf2 translocation into nucleus. However, SF-mediated inhibitory effect on the release of IL-6 and MCP-1 cytokines was reversed in the Nrf2 or HO-1 knockdown condition. This result indicated that SF-mediated inhibition of obesity-induced inflammation was dependent on Nrf2 activation.
引用
收藏
页码:1507 / 1516
页数:10
相关论文
共 5 条
  • [1] Brassinin, a phytoalexin in cruciferous vegetables, suppresses obesity-induced inflammatory responses through the Nrf2-HO-1 signaling pathway in an adipocyte-macrophage co-culture system
    Kang, Bobin
    Kim, Chae Young
    Hwang, Jisu
    Suh, Hyung Joo
    Choi, Hyeon-Son
    PHYTOTHERAPY RESEARCH, 2019, 33 (05) : 1426 - 1437
  • [2] Dual Beneficial Effects of Methylnissolin-3-O-β-D-Glucopyranoside on Obesity-Induced Inflammatory Responses in Adipocyte-Macrophage Co-Culture
    Lee, Dahae
    Wu, Xiaohua
    Lange, Ingo
    Cao, Shugeng
    Kang, Ki Sung
    PLANTS-BASEL, 2022, 11 (13):
  • [3] Punicalagin, a Pomegranate-Derived Ellagitannin, Suppresses Obesity and Obesity-Induced Inflammatory Responses Via the Nrf2/Keap1 Signaling Pathway
    Kang, Bobin
    Kim, Chae Young
    Hwang, Jisu
    Jo, Kyungae
    Kim, Singeun
    Suh, Hyung Joo
    Choi, Hyeon-Son
    MOLECULAR NUTRITION & FOOD RESEARCH, 2019, 63 (22)
  • [4] Parthenolide, a feverfew-derived phytochemical, ameliorates obesity and obesity-induced inflammatory responses via the Nrf2/Keap1 pathway
    Kim, Chae Young
    Kang, Bobin
    Suh, Hyung Joo
    Choi, Hyeon-Son
    PHARMACOLOGICAL RESEARCH, 2019, 145
  • [5] Zinc L-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2/HO-1 signaling pathway
    Ooi, Theng Choon
    Chan, Kok Meng
    Sharif, Razinah
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2017, 39 (05) : 259 - 267